News

ICHOM has convened a network of global breast cancer treatment experts who work together to improve clinical practice and patient outcomes. The collaborative serves to share best practices, and identify areas for learning including optimal clinical pathways, equity, and shared decision-making. Phase I is 2 years with 4-5 participants. The following participants have confirmed their
ICHOM is thrilled to announce the launch of its groundbreaking Set of Patient-Centered Outcome Measures for Adults living with Obesity. This innovative set identifies a core collection of outcomes that are vital to patients, encompassing their physical, social, and emotional well-being in daily life. A huge thank you to our amazing sponsors: Novo Nordisk, Eli
ICHOM had the chance to sit down with Rhino Health for an exclusive interview we’re pleased to share. Continue reading to hear what we discussed with Chris Laws, Chief Operating Officer. Can you give us a brief introduction to Rhino Health and what you do? A: Rhino Health helps to activate the world’s health data.
We are pleased to announce that the ICHOM Neurodevelopmental Disorders (NDD) Working Group’s article detailing the development process of the NDD Set has now been published in JAMA Network Open. The article sheds light on the rigorous methodology and components of patient-centered research that were followed to develop a Set that emphasizes the importance of
The ICHOM Addiction (SUD) Working Group’s article detailing the development process of the SUD Set has now been published in the Journal of Clinical Medicine. The article sheds light on the rigorous methodology and components of patient-centered research that were followed to develop a Set that emphasizes the importance of measuring outcomes that matter most

Register for the ICHOM newsletter

Receive updates on progress made by ICHOM and opportunities to get involved

TOP